Actos and Alzheimer's

New research at the University of Virginia Health System and Case Western Reserve University shows that the type 2 diabetes drug pioglitazone (Actos) may hold promise in treating Alzheimer’s Disease. According to Dr. David Geldmacher, one of the study authors, “We believe that the drug may reduce the body’s inflammatory reaction to one of the toxic components that builds up in Alzheimer’s, called amyloid plaque,” said Dr. David Geldmacher, an associate professor of neurology at UVa.

A 2005 study out of Brown University found that insulin levels drop and insulin resistance increases significantly in the brains of patients with Alzheimer's. As a result, researchers postulated that Alzheimer's may actually be a "type 3 diabetes."

Comments

1. At 04:15 AM on Fri, Sep 7, 2007 narconon wrote:

   Interesting informations. I didn't know that between diabetes and Alzheimer disease is a connection. If this is true then this disease will never be cured.